Orient EuroPharma Statistics

Total Valuation

TPEX:4120 has a market cap or net worth of TWD 4.19 billion. The enterprise value is 6.94 billion.

Market Cap	4.19B
Enterprise Value	6.94B

Important Dates

The last earnings date was Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4120 has 86.75 million shares outstanding. The number of shares has decreased by -0.10% in one year.

Current Share Class	86.75M
Shares Outstanding	86.75M
Shares Change (YoY)	-0.10%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	13.62%
Owned by Institutions (%)	1.38%
Float	32.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.94
PB Ratio	0.68
P/TBV Ratio	0.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 134.81, with an EV/FCF ratio of -56.79.

EV / Earnings	-19.94
EV / Sales	1.56
EV / EBITDA	134.81
EV / EBIT	n/a
EV / FCF	-56.79

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.60.

Current Ratio	1.11
Quick Ratio	0.78
Debt / Equity	0.60
Debt / EBITDA	37.90
Debt / FCF	-30.64
Interest Coverage	-0.90

Financial Efficiency

Return on equity (ROE) is -5.54% and return on invested capital (ROIC) is -0.61%.

Return on Equity (ROE)	-5.54%
Return on Assets (ROA)	-0.52%
Return on Invested Capital (ROIC)	-0.61%
Return on Capital Employed (ROCE)	-1.10%
Revenue Per Employee	13.11M
Profits Per Employee	-1.03M
Employee Count	339
Asset Turnover	0.39
Inventory Turnover	2.32

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.10% in the last 52 weeks. The beta is 0.19, so TPEX:4120's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+13.10%
50-Day Moving Average	47.69
200-Day Moving Average	48.67
Relative Strength Index (RSI)	62.27
Average Volume (20 Days)	31,293

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4120 had revenue of TWD 4.44 billion and -347.80 million in losses. Loss per share was -4.00.

Revenue	4.44B
Gross Profit	2.10B
Operating Income	-93.73M
Pretax Income	-176.33M
Net Income	-347.80M
EBITDA	62.22M
EBIT	-93.73M
Loss Per Share	-4.00

Full Income Statement

Balance Sheet

The company has 1.68 billion in cash and 3.74 billion in debt, giving a net cash position of -2.06 billion or -23.74 per share.

Cash & Cash Equivalents	1.68B
Total Debt	3.74B
Net Cash	-2.06B
Net Cash Per Share	-23.74
Equity (Book Value)	6.19B
Book Value Per Share	63.41
Working Capital	362.46M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.40 million and capital expenditures -98.75 million, giving a free cash flow of -122.15 million.

Operating Cash Flow	-23.40M
Capital Expenditures	-98.75M
Free Cash Flow	-122.15M
FCF Per Share	-1.41

Full Cash Flow Statement

Margins

Gross margin is 47.16%, with operating and profit margins of -2.11% and -7.83%.

Gross Margin	47.16%
Operating Margin	-2.11%
Pretax Margin	-3.97%
Profit Margin	-7.83%
EBITDA Margin	1.40%
EBIT Margin	-2.11%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.07%.

Dividend Per Share	1.00
Dividend Yield	2.07%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	0.10%
Shareholder Yield	2.17%
Earnings Yield	-8.29%
FCF Yield	-2.91%

Dividend Details

Stock Splits

The last stock split was on July 28, 2010. It was a forward split with a ratio of 1.16.

Last Split Date	Jul 28, 2010
Split Type	Forward
Split Ratio	1.16

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a